Hepion Pharmaceuticals (3360.MU) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Next
-89.69
-89.35
-89.02
-88.69

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Hepion Pharmaceuticals (3360.MU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts